array(40) {
  [0]=>
  string(4) "2365"
  ["article_id"]=>
  string(4) "2365"
  [1]=>
  string(74) "Medical News Today: How do cancer-causing bacteria take over our stomachs?"
  ["article_title"]=>
  string(74) "Medical News Today: How do cancer-causing bacteria take over our stomachs?"
  [2]=>
  string(150) "H. pylori live in the stomachs of around 50% of all humans. Despite their prevalence, little is known about how they can survive inside us for a lifet"
  ["short_description"]=>
  string(150) "H. pylori live in the stomachs of around 50% of all humans. Despite their prevalence, little is known about how they can survive inside us for a lifet"
  [3]=>
  string(154) "H. pylori live in the stomachs of around 50% of all humans. Despite their prevalence, little is known about how they can survive inside us for a lifetime."
  ["description"]=>
  string(154) "H. pylori live in the stomachs of around 50% of all humans. Despite their prevalence, little is known about how they can survive inside us for a lifetime."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "97"
  ["rss_id"]=>
  string(2) "97"
  [14]=>
  string(52) "https://www.medicalnewstoday.com/articles/325119.php"
  ["blog_url"]=>
  string(52) "https://www.medicalnewstoday.com/articles/325119.php"
  [15]=>
  string(19) "2019-05-08 15:00:00"
  ["add_date"]=>
  string(19) "2019-05-08 15:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:42:18"
  ["create_at"]=>
  string(19) "2019-05-09 16:42:18"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1985"
  ["article_id"]=>
  string(4) "1985"
  [1]=>
  string(165) "CytoDyn Provides Updated Pre-Clinical Data Showing Leronlimab (PRO 140) Continues to Suppress Breast Cancer Metastatic Burden >98% Compared with Untreated Animals"
  ["article_title"]=>
  string(165) "CytoDyn Provides Updated Pre-Clinical Data Showing Leronlimab (PRO 140) Continues to Suppress Breast Cancer Metastatic Burden >98% Compared with Untreated Animals"
  [2]=>
  string(150) "VANCOUVER, Washington, May 08, 2019 (GLOBE NEWSWIRE) -- CytoDyn Inc., (“CytoDyn” or the “Company”), a late stage biotechnology"
  ["short_description"]=>
  string(150) "VANCOUVER, Washington, May 08, 2019 (GLOBE NEWSWIRE) -- CytoDyn Inc., (“CytoDyn” or the “Company”), a late stage biotechnology"
  [3]=>
  string(244) "VANCOUVER, Washington, May 08, 2019 (GLOBE NEWSWIRE) -- CytoDyn Inc., (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple..."
  ["description"]=>
  string(244) "VANCOUVER, Washington, May 08, 2019 (GLOBE NEWSWIRE) -- CytoDyn Inc., (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(300) "https://www.drugs.com/clinical_trials/cytodyn-provides-updated-pre-clinical-data-showing-leronlimab-pro-140-continues-suppress-breast-18134.html?utm_source=ddc&utm_medium=rss&utm_campaign=CytoDyn+Provides+Updated+Pre-Clinical+Data+Showing+Leronlimab+%28PRO+140%29+Continues+to+Suppress+Breast+Cancer+"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/clinical_trials/cytodyn-provides-updated-pre-clinical-data-showing-leronlimab-pro-140-continues-suppress-breast-18134.html?utm_source=ddc&utm_medium=rss&utm_campaign=CytoDyn+Provides+Updated+Pre-Clinical+Data+Showing+Leronlimab+%28PRO+140%29+Continues+to+Suppress+Breast+Cancer+"
  [15]=>
  string(19) "2019-05-08 14:05:43"
  ["add_date"]=>
  string(19) "2019-05-08 14:05:43"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:57"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:57"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2494"
  ["article_id"]=>
  string(4) "2494"
  [1]=>
  string(120) "Merck Announces Results from Phase 2 Trial of Investigational 15-valent Pneumococcal Conjugate Vaccine (V114) in Infants"
  ["article_title"]=>
  string(120) "Merck Announces Results from Phase 2 Trial of Investigational 15-valent Pneumococcal Conjugate Vaccine (V114) in Infants"
  [2]=>
  string(150) "KENILWORTH, N.J.--(BUSINESS WIRE) May 8, 2019 --Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from "
  ["short_description"]=>
  string(150) "KENILWORTH, N.J.--(BUSINESS WIRE) May 8, 2019 --Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from "
  [3]=>
  string(251) "KENILWORTH, N.J.--(BUSINESS WIRE) May 8, 2019 --Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from a Phase 2 trial (NCT02982972 ) evaluating the safety, tolerability and immunogenicity of V114, the..."
  ["description"]=>
  string(251) "KENILWORTH, N.J.--(BUSINESS WIRE) May 8, 2019 --Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from a Phase 2 trial (NCT02982972 ) evaluating the safety, tolerability and immunogenicity of V114, the..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(300) "https://www.drugs.com/clinical_trials/merck-announces-results-phase-2-trial-investigational-15-valent-pneumococcal-conjugate-vaccine-v114-18137.html?utm_source=ddc&utm_medium=rss&utm_campaign=Merck+Announces+Results+from+Phase+2+Trial+of+Investigational+15-valent+Pneumococcal+Conjugate+Vaccine+%28V1"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/clinical_trials/merck-announces-results-phase-2-trial-investigational-15-valent-pneumococcal-conjugate-vaccine-v114-18137.html?utm_source=ddc&utm_medium=rss&utm_campaign=Merck+Announces+Results+from+Phase+2+Trial+of+Investigational+15-valent+Pneumococcal+Conjugate+Vaccine+%28V1"
  [15]=>
  string(19) "2019-05-08 13:05:54"
  ["add_date"]=>
  string(19) "2019-05-08 13:05:54"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:18:34"
  ["create_at"]=>
  string(19) "2019-05-23 14:18:34"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2495"
  ["article_id"]=>
  string(4) "2495"
  [1]=>
  string(152) "AAN 2019: Two New Analyses of Lasmiditan Phase 3 Studies Measured Onset of Effect and the Effect of Lasmiditan in Patients with Prior Triptan Experience"
  ["article_title"]=>
  string(152) "AAN 2019: Two New Analyses of Lasmiditan Phase 3 Studies Measured Onset of Effect and the Effect of Lasmiditan in Patients with Prior Triptan Experience"
  [2]=>
  string(150) "INDIANAPOLIS, May 8, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new data and post-hoc analyses for lasmiditan, an investig"
  ["short_description"]=>
  string(150) "INDIANAPOLIS, May 8, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new data and post-hoc analyses for lasmiditan, an investig"
  [3]=>
  string(251) "INDIANAPOLIS, May 8, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new data and post-hoc analyses for lasmiditan, an investigational, oral, first-in-class molecule for the acute treatment of migraine, being presented at the..."
  ["description"]=>
  string(251) "INDIANAPOLIS, May 8, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new data and post-hoc analyses for lasmiditan, an investigational, oral, first-in-class molecule for the acute treatment of migraine, being presented at the..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(300) "https://www.drugs.com/clinical_trials/aan-2019-two-new-analyses-lasmiditan-phase-3-studies-measured-onset-lasmiditan-patients-prior-18139.html?utm_source=ddc&utm_medium=rss&utm_campaign=AAN+2019%3A+Two+New+Analyses+of+Lasmiditan+Phase+3+Studies+Measured+Onset+of+Effect+and+the+Effect+of+Lasmiditan+i"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/clinical_trials/aan-2019-two-new-analyses-lasmiditan-phase-3-studies-measured-onset-lasmiditan-patients-prior-18139.html?utm_source=ddc&utm_medium=rss&utm_campaign=AAN+2019%3A+Two+New+Analyses+of+Lasmiditan+Phase+3+Studies+Measured+Onset+of+Effect+and+the+Effect+of+Lasmiditan+i"
  [15]=>
  string(19) "2019-05-08 13:05:45"
  ["add_date"]=>
  string(19) "2019-05-08 13:05:45"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:18:34"
  ["create_at"]=>
  string(19) "2019-05-23 14:18:34"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2366"
  ["article_id"]=>
  string(4) "2366"
  [1]=>
  string(44) "Medical News Today: What causes black mucus?"
  ["article_title"]=>
  string(44) "Medical News Today: What causes black mucus?"
  [2]=>
  string(150) "Black mucus or phlegm is usually a sign of an underlying condition, smoking, or exposure to pollutants. It may clear up on its own, but it sometimes r"
  ["short_description"]=>
  string(150) "Black mucus or phlegm is usually a sign of an underlying condition, smoking, or exposure to pollutants. It may clear up on its own, but it sometimes r"
  [3]=>
  string(228) "Black mucus or phlegm is usually a sign of an underlying condition, smoking, or exposure to pollutants. It may clear up on its own, but it sometimes requires treatment. Here, find out what causes black mucus and how to treat it."
  ["description"]=>
  string(228) "Black mucus or phlegm is usually a sign of an underlying condition, smoking, or exposure to pollutants. It may clear up on its own, but it sometimes requires treatment. Here, find out what causes black mucus and how to treat it."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "97"
  ["rss_id"]=>
  string(2) "97"
  [14]=>
  string(52) "https://www.medicalnewstoday.com/articles/325120.php"
  ["blog_url"]=>
  string(52) "https://www.medicalnewstoday.com/articles/325120.php"
  [15]=>
  string(19) "2019-05-08 12:00:00"
  ["add_date"]=>
  string(19) "2019-05-08 12:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:42:18"
  ["create_at"]=>
  string(19) "2019-05-09 16:42:18"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2367"
  ["article_id"]=>
  string(4) "2367"
  [1]=>
  string(56) "Medical News Today: What to know about excessive burping"
  ["article_title"]=>
  string(56) "Medical News Today: What to know about excessive burping"
  [2]=>
  string(150) "Excessive burping can occur as a result of gastroesophageal reflux disease (GERD), consuming certain foods, or aerophagia or supragastric belching. Th"
  ["short_description"]=>
  string(150) "Excessive burping can occur as a result of gastroesophageal reflux disease (GERD), consuming certain foods, or aerophagia or supragastric belching. Th"
  [3]=>
  string(212) "Excessive burping can occur as a result of gastroesophageal reflux disease (GERD), consuming certain foods, or aerophagia or supragastric belching. The treatment options will depend on the cause. Learn more here."
  ["description"]=>
  string(212) "Excessive burping can occur as a result of gastroesophageal reflux disease (GERD), consuming certain foods, or aerophagia or supragastric belching. The treatment options will depend on the cause. Learn more here."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "97"
  ["rss_id"]=>
  string(2) "97"
  [14]=>
  string(52) "https://www.medicalnewstoday.com/articles/325121.php"
  ["blog_url"]=>
  string(52) "https://www.medicalnewstoday.com/articles/325121.php"
  [15]=>
  string(19) "2019-05-08 10:00:00"
  ["add_date"]=>
  string(19) "2019-05-08 10:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:42:19"
  ["create_at"]=>
  string(19) "2019-05-09 16:42:19"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2368"
  ["article_id"]=>
  string(4) "2368"
  [1]=>
  string(50) "Medical News Today: Possible causes of facial pain"
  ["article_title"]=>
  string(50) "Medical News Today: Possible causes of facial pain"
  [2]=>
  string(150) "Common causes of facial pain include headaches and injuries. However, facial pain can also result from dental problems, infections, and nerve disorder"
  ["short_description"]=>
  string(150) "Common causes of facial pain include headaches and injuries. However, facial pain can also result from dental problems, infections, and nerve disorder"
  [3]=>
  string(257) "Common causes of facial pain include headaches and injuries. However, facial pain can also result from dental problems, infections, and nerve disorders. People who experience severe, recurring, or persistent facial pain should see a doctor. Learn more here."
  ["description"]=>
  string(257) "Common causes of facial pain include headaches and injuries. However, facial pain can also result from dental problems, infections, and nerve disorders. People who experience severe, recurring, or persistent facial pain should see a doctor. Learn more here."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "97"
  ["rss_id"]=>
  string(2) "97"
  [14]=>
  string(52) "https://www.medicalnewstoday.com/articles/325116.php"
  ["blog_url"]=>
  string(52) "https://www.medicalnewstoday.com/articles/325116.php"
  [15]=>
  string(19) "2019-05-08 08:00:00"
  ["add_date"]=>
  string(19) "2019-05-08 08:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:42:19"
  ["create_at"]=>
  string(19) "2019-05-09 16:42:19"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1967"
  ["article_id"]=>
  string(4) "1967"
  [1]=>
  string(90) "Substandard and falsified medicines: global and local efforts to address a growing problem"
  ["article_title"]=>
  string(90) "Substandard and falsified medicines: global and local efforts to address a growing problem"
  [2]=>
  string(86) "Substandard and falsified medicines pose a risk to public health all around the world."
  ["short_description"]=>
  string(86) "Substandard and falsified medicines pose a risk to public health all around the world."
  [3]=>
  string(86) "Substandard and falsified medicines pose a risk to public health all around the world."
  ["description"]=>
  string(86) "Substandard and falsified medicines pose a risk to public health all around the world."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "12"
  ["rss_id"]=>
  string(2) "12"
  [14]=>
  string(174) "https://www.pharmaceutical-journal.com/research/perspective-article/substandard-and-falsified-medicines-global-and-local-efforts-to-address-a-growing-problem/20206309.article"
  ["blog_url"]=>
  string(174) "https://www.pharmaceutical-journal.com/research/perspective-article/substandard-and-falsified-medicines-global-and-local-efforts-to-address-a-growing-problem/20206309.article"
  [15]=>
  string(19) "2019-05-08 08:00:00"
  ["add_date"]=>
  string(19) "2019-05-08 08:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:55"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:55"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2021"
  ["article_id"]=>
  string(4) "2021"
  [1]=>
  string(66) "FDA Warns French Drugmaker for Out-of-Specification Investigations"
  ["article_title"]=>
  string(66) "FDA Warns French Drugmaker for Out-of-Specification Investigations"
  [2]=>
  string(153) "&#nl        Laboratoires Claires drew a warning letter from the FDA for shoddy out-of-specification investigations and other violations at its Pontoise, "
  ["short_description"]=>
  string(153) "&#nl        Laboratoires Claires drew a warning letter from the FDA for shoddy out-of-specification investigations and other violations at its Pontoise, "
  [3]=>
  string(179) "&#nl        Laboratoires Claires drew a warning letter from the FDA for shoddy out-of-specification investigations and other violations at its Pontoise, France facility.&#nl      "
  ["description"]=>
  string(179) "&#nl        Laboratoires Claires drew a warning letter from the FDA for shoddy out-of-specification investigations and other violations at its Pontoise, France facility.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(106) "https://www.fdanews.com/articles/191220-fda-warns-french-drugmaker-for-out-of-specification-investigations"
  ["blog_url"]=>
  string(106) "https://www.fdanews.com/articles/191220-fda-warns-french-drugmaker-for-out-of-specification-investigations"
  [15]=>
  string(19) "2019-05-08 05:53:18"
  ["add_date"]=>
  string(19) "2019-05-08 05:53:18"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:57"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:57"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2022"
  ["article_id"]=>
  string(4) "2022"
  [1]=>
  string(76) "Pennsylvania Compounder Calls for Oxitriptan’s Inclusion on 503A List"
  ["article_title"]=>
  string(76) "Pennsylvania Compounder Calls for Oxitriptan’s Inclusion on 503A List"
  [2]=>
  string(163) "&#nl        Pennsylvania compounder Summit Health Pharmacy has petitioned the FDA to include oxitriptan on the agency’s 503A bulk substances list—and"
  ["short_description"]=>
  string(163) "&#nl        Pennsylvania compounder Summit Health Pharmacy has petitioned the FDA to include oxitriptan on the agency’s 503A bulk substances list—and"
  [3]=>
  string(243) "&#nl        Pennsylvania compounder Summit Health Pharmacy has petitioned the FDA to include oxitriptan on the agency’s 503A bulk substances list—and says the agency should also allow it for compounding in the meantime.&#nl      "
  ["description"]=>
  string(243) "&#nl        Pennsylvania compounder Summit Health Pharmacy has petitioned the FDA to include oxitriptan on the agency’s 503A bulk substances list—and says the agency should also allow it for compounding in the meantime.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(108) "https://www.fdanews.com/articles/191219-pennsylvania-compounder-calls-for-oxitriptans-inclusion-on-503a-list"
  ["blog_url"]=>
  string(108) "https://www.fdanews.com/articles/191219-pennsylvania-compounder-calls-for-oxitriptans-inclusion-on-503a-list"
  [15]=>
  string(19) "2019-05-08 05:52:15"
  ["add_date"]=>
  string(19) "2019-05-08 05:52:15"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:57"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:57"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2023"
  ["article_id"]=>
  string(4) "2023"
  [1]=>
  string(60) "Pfizer Recommends Suffixes for Biosimilar Reference Products"
  ["article_title"]=>
  string(60) "Pfizer Recommends Suffixes for Biosimilar Reference Products"
  [2]=>
  string(153) "&#nl        Pfizer is calling on the FDA to retroactively assign four-letter suffixes to biologics that act as reference products for innovative biosimil"
  ["short_description"]=>
  string(153) "&#nl        Pfizer is calling on the FDA to retroactively assign four-letter suffixes to biologics that act as reference products for innovative biosimil"
  [3]=>
  string(167) "&#nl        Pfizer is calling on the FDA to retroactively assign four-letter suffixes to biologics that act as reference products for innovative biosimilars.&#nl      "
  ["description"]=>
  string(167) "&#nl        Pfizer is calling on the FDA to retroactively assign four-letter suffixes to biologics that act as reference products for innovative biosimilars.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(100) "https://www.fdanews.com/articles/191218-pfizer-recommends-suffixes-for-biosimilar-reference-products"
  ["blog_url"]=>
  string(100) "https://www.fdanews.com/articles/191218-pfizer-recommends-suffixes-for-biosimilar-reference-products"
  [15]=>
  string(19) "2019-05-08 05:51:00"
  ["add_date"]=>
  string(19) "2019-05-08 05:51:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:57"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:57"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2110"
  ["article_id"]=>
  string(4) "2110"
  [1]=>
  string(57) "SMA, Migraine Data Lead Neuro Highlights from AAN Meeting"
  ["article_title"]=>
  string(57) "SMA, Migraine Data Lead Neuro Highlights from AAN Meeting"
  [2]=>
  string(150) "The American Academy of Neurology meeting in Philadelphia is rolling on through the end of this week. There has been plenty of news to digest already."
  ["short_description"]=>
  string(150) "The American Academy of Neurology meeting in Philadelphia is rolling on through the end of this week. There has been plenty of news to digest already."
  [3]=>
  string(383) "The American Academy of Neurology meeting in Philadelphia is rolling on through the end of this week. There has been plenty of news to digest already. New clinical data could herald cutting-edge treatments for migraine, the rare disease spinal muscular atrophy, the deadly neurological disorder amyotrophic lateral sclerosis, and more. Xconomy previewed the conference last […]"
  ["description"]=>
  string(383) "The American Academy of Neurology meeting in Philadelphia is rolling on through the end of this week. There has been plenty of news to digest already. New clinical data could herald cutting-edge treatments for migraine, the rare disease spinal muscular atrophy, the deadly neurological disorder amyotrophic lateral sclerosis, and more. Xconomy previewed the conference last […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(97) "https://xconomy.com/national/2019/05/07/sma-migraine-data-lead-neuro-highlights-from-aan-meeting/"
  ["blog_url"]=>
  string(97) "https://xconomy.com/national/2019/05/07/sma-migraine-data-lead-neuro-highlights-from-aan-meeting/"
  [15]=>
  string(19) "2019-05-08 05:10:26"
  ["add_date"]=>
  string(19) "2019-05-08 05:10:26"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:33"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}